Reliability and Validity of Urdu Version of Mini-BESTest in Persons With Parkinson's Disease

Various clinical scales are available to investigate balance impairment, Mini-BESTest is one of them. Thus, this study aims to translate the Mini-BESTest into Urdu and investigate its psychometric properties in the Pakistani Parkinson's population with dynamic balance impairment.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Balance Basal Ganglia Diseases Brain Diseases Central Nervous System Diseases Movement Disorders Nervous System Diseases Neurodegenerative Diseases Parkinson Disease Parkinsonian Disorders Synucleinopathies

Age range

50 year–70 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Ripah International University

Faisalabad, Punjab Province, 38000, Pakistan

About this study

The aim of study is to translate and culturally adapt Mini-BESTest into Urdu language and secondly to investigate the reliability and validity of Urdu Version of Mini-BEStest in Parkinson's Pakistani population. This study will be cross sectional survey study in which convenience sampling technique will be used.

The results of study will help to know the validity and reliability of Mini-BESTest in Urdu version with dynamic balance impairments in Parkinson's population. The reliability of the scale will be checked through internal consistency and test-retest methods. Internal consistency will be analyzed with Cronbach's alpha value. Test-retest reliability will be assessed using an intraclass correlation coefficient with 80 patients.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

All persons with Parkinson disease and ability to follow commands were included in the study.
living independently in the community
able to walk 6 m independently
willing to participate in the study.

Exclusion criteria

History of other neurological disorders
Musculoskeletal damage which affects walking ability
Presence of serious medical condition
History of surgical treatments for Parkinson disease
Not willing to participate in the study
history of faint, vertigo, dizziness,or taking medications which can cause dizziness
history of any medical condition which can affect balance.

Treatment and study plan

Primary outcomes

Mini-BESTest Scale

Time frame: 1st day

A measuring instrument for the evaluation of dynamic balance is the Mini-BESTest Scale. Each item is scored from 0 to 2 , higher score 2 means better balance performance and 0 showing worst balance performance . Mini-BESTest 28 is the highest result possible
Berg Balance Scale

Time frame: 1st day

The Berg Balance Scale is an objective assessment of balance performance based on 14 items common to everyday activities. It is a 14 items scale that rates 0 (unable to perform) to 4 (normal performance) for each item. The total score is 56 points. Higher score higher balance ability.
Brief -BESTest Scale

Time frame: 1st day

The Brief -BESTest Scale is a shorter version of the BEStest Scale and takes less time to administer. It consist of eight items from six section . Each item is scored from 0 to 3, higher score means better balance performance. All items scores are summed to obtain the total score which ranges from 0 to 24.

Sponsors and collaborators

Lead sponsor

Riphah International University

Other

Registry information

Official study title

Is the Urdu Version of Mini-BESTest a Reliable and Valid Tool for Assessing the Dynamic Balance Impairments of Patients With Parkinson's Disease?

Important dates

Study start: 2021
Primary completion: 2022
Study completion: 2022
First posted: Feb 2, 2022
Registry last updated: Mar 10, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed